tirzepatide vs semaglutide weight loss studies vs. for Obesity Tirzepatide vs. Semaglutide: Which Weight

5) Polymer sustained-release agents: Develop sustained-release dosage forms to extend drug release time

The STEP 1 trial showed an average weight loss of 14.9% at 2.4mg over 68 weeks, but some participants lost nearly as much weight at lower doses with fewer side effects

LaBarre, J

Safety and Side Effects GLP-1 drugs share a few common side effects

The good news: strength training 2 to 3 times per week [read our Beginner Strength Blueprint] and prioritizing protein can protect most of your muscle while the medication helps you lose fat

Whether you are just beginning to explore your options or you have already been on medication and want proper medical oversight going forward, this is a practice worth talking to